E
Zentalis Pharmaceuticals, Inc. ZNTL
$1.63 -$0.12-6.86% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -33.76% -33.76% -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -33.76% -33.76% -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -33.76% -33.76% -- -- --
SG&A Expenses 11.83% 28.61% 35.37% 7.36% 17.46%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -24.50% -10.59% 0.37% 5.07% 13.90%
Operating Income 22.79% 6.19% 26.18% 11.99% 3.79%
Income Before Tax 16.15% -2.09% 43.43% 37.64% 32.10%
Income Tax Expenses -176.07% 106.01% 129.45% 129.90% 130.02%
Earnings from Continuing Operations 16.40% -2.37% 43.26% 37.37% 31.75%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -100.00% -100.00% -75.44% -52.38% -67.71%
Net Income 16.37% -2.41% 43.24% 37.37% 31.73%
EBIT 22.79% 6.19% 26.18% 11.99% 3.79%
EBITDA 22.81% 6.17% 26.28% 12.02% 3.77%
EPS Basic 17.08% 6.21% 48.92% 45.69% 43.02%
Normalized Basic EPS 0.95% -12.78% 39.57% 43.07% 40.13%
EPS Diluted 17.14% 6.27% 48.91% 45.69% 43.02%
Normalized Diluted EPS 0.97% -12.76% 39.55% 43.06% 40.12%
Average Basic Shares Outstanding 0.94% 4.38% 8.72% 14.09% 20.58%
Average Diluted Shares Outstanding 0.84% 4.27% 8.83% 14.21% 20.71%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --